Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (239)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
61
2025
2999
4.130
Why?
Antibodies, Bispecific
6
2025
88
1.130
Why?
Hematopoietic Stem Cell Transplantation
8
2024
597
0.890
Why?
Leukemia, Plasma Cell
2
2020
33
0.820
Why?
Plasma Cells
7
2025
234
0.760
Why?
Immunotherapy, Adoptive
5
2024
155
0.680
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
120
0.660
Why?
Bone Marrow
10
2022
361
0.660
Why?
B-Cell Maturation Antigen
7
2025
92
0.650
Why?
Neoplasms, Plasma Cell
3
2024
35
0.610
Why?
Humans
70
2025
52114
0.580
Why?
Chromosome Deletion
2
2023
139
0.550
Why?
Gene Expression Profiling
11
2025
1101
0.540
Why?
Positron-Emission Tomography
5
2025
297
0.530
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.530
Why?
Diffusion Magnetic Resonance Imaging
4
2025
132
0.530
Why?
Neoplasm, Residual
7
2025
170
0.520
Why?
Prognosis
17
2025
2093
0.500
Why?
Clinical Trials as Topic
4
2022
463
0.500
Why?
Tumor Suppressor Protein p53
2
2017
224
0.490
Why?
Transplantation, Autologous
9
2024
480
0.490
Why?
Gene Expression Regulation, Neoplastic
6
2021
853
0.490
Why?
Aged
25
2025
10142
0.470
Why?
Proteasome Inhibitors
1
2016
101
0.460
Why?
Immunologic Factors
1
2016
117
0.460
Why?
Immunotherapy
1
2016
240
0.420
Why?
Translocation, Genetic
5
2021
265
0.410
Why?
Antibodies, Monoclonal
2
2022
475
0.400
Why?
Mutation
7
2022
1318
0.400
Why?
Neoplasm Proteins
4
2020
328
0.380
Why?
Neutropenia
2
2023
113
0.370
Why?
Survival Analysis
8
2024
667
0.360
Why?
Stem Cell Transplantation
4
2022
186
0.360
Why?
Neoplasms
2
2012
1288
0.360
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.360
Why?
Lymphocytes
1
2012
146
0.350
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Cancer Vaccines
1
2011
78
0.330
Why?
Neoplasm Recurrence, Local
7
2024
630
0.330
Why?
Middle Aged
23
2025
13028
0.320
Why?
Aged, 80 and over
10
2025
3382
0.310
Why?
Female
29
2025
28055
0.310
Why?
Cytokines
1
2012
621
0.300
Why?
Tumor Microenvironment
3
2024
246
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
1020
0.280
Why?
Hematologic Neoplasms
2
2022
100
0.280
Why?
Male
27
2025
26652
0.270
Why?
Adult
19
2025
14095
0.270
Why?
Combined Modality Therapy
4
2024
634
0.260
Why?
Atrial Fibrillation
2
2022
200
0.250
Why?
Disease Progression
7
2025
866
0.240
Why?
Fluorodeoxyglucose F18
4
2021
181
0.230
Why?
Proto-Oncogene Proteins B-raf
3
2020
77
0.220
Why?
Immunoglobulins, Intravenous
1
2025
63
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
Neoplasms, Second Primary
1
2024
75
0.210
Why?
Chromosomes, Human, Pair 1
2
2023
95
0.200
Why?
Risk Factors
9
2024
3922
0.190
Why?
Paraproteinemias
1
2022
72
0.190
Why?
Drug Approval
1
2022
38
0.190
Why?
Immunoconjugates
1
2022
36
0.190
Why?
Osteolysis
1
2022
74
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
Lymphoma, B-Cell
1
2022
61
0.180
Why?
Treatment Outcome
7
2022
5456
0.180
Why?
Recurrence
6
2024
680
0.180
Why?
Epigenomics
1
2021
74
0.180
Why?
Patient Participation
1
2022
68
0.180
Why?
T-Lymphocytes
4
2024
316
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Cell Cycle
1
2021
237
0.160
Why?
Practice Guidelines as Topic
1
2023
494
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Bone Resorption
1
2022
302
0.160
Why?
Bone Diseases
1
2021
92
0.160
Why?
Retrospective Studies
8
2025
6610
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Disease-Free Survival
5
2019
462
0.150
Why?
Antigens, CD
1
2020
215
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Healthcare Disparities
1
2022
296
0.150
Why?
Spleen
1
2019
169
0.140
Why?
Spinal Fractures
1
2018
38
0.140
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Antineoplastic Agents
2
2024
1214
0.140
Why?
Brain Neoplasms
2
2011
287
0.140
Why?
Bacteremia
1
2019
89
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Retinoblastoma Binding Proteins
1
2017
11
0.130
Why?
Flow Cytometry
1
2018
397
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Epigenesis, Genetic
1
2020
401
0.130
Why?
Pelvis
1
2017
66
0.130
Why?
Cell Proliferation
4
2023
1017
0.130
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
105
0.130
Why?
Survival Rate
4
2020
945
0.130
Why?
Immunoglobulin Light Chains
1
2017
90
0.120
Why?
Clonal Evolution
1
2016
59
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Ubiquitin-Protein Ligases
1
2017
136
0.120
Why?
Gene Expression
1
2018
618
0.120
Why?
Transcriptome
3
2025
363
0.110
Why?
Animals
4
2024
13332
0.110
Why?
Cystatin M
2
2024
17
0.100
Why?
Cross-Sectional Studies
3
2023
1665
0.100
Why?
Cardiovascular Diseases
1
2017
493
0.090
Why?
Follow-Up Studies
3
2024
2282
0.090
Why?
Lymphoma, Non-Hodgkin
1
2011
58
0.090
Why?
Astrocytoma
1
2011
19
0.090
Why?
Disease Models, Animal
1
2016
1467
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
In Situ Hybridization, Fluorescence
2
2023
262
0.080
Why?
Glioma
1
2011
77
0.080
Why?
Genomics
2
2023
265
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Remission Induction
2
2021
218
0.080
Why?
Tumor Burden
2
2020
133
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
68
0.080
Why?
Histones
2
2021
316
0.070
Why?
Vaccination
1
2011
296
0.070
Why?
Transcription Factors
2
2023
564
0.070
Why?
Radiopharmaceuticals
2
2021
199
0.070
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Models, Biological
1
2011
731
0.070
Why?
Cell Differentiation
2
2022
670
0.070
Why?
Kaplan-Meier Estimate
2
2019
482
0.060
Why?
Imaging, Three-Dimensional
2
2017
147
0.060
Why?
Biopsy
2
2018
599
0.060
Why?
ROC Curve
1
2025
250
0.060
Why?
Arkansas
2
2021
2016
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
112
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
128
0.050
Why?
X-Ray Microtomography
1
2024
77
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
54
0.050
Why?
Antibodies
1
2024
148
0.050
Why?
Mice
2
2024
5877
0.050
Why?
Signal Transduction
2
2021
1699
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
50
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
United States Food and Drug Administration
1
2022
90
0.050
Why?
Patient Selection
1
2023
265
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Bone Marrow Transplantation
1
2022
110
0.040
Why?
Dexamethasone
1
2024
435
0.040
Why?
Chromosome Aberrations
1
2023
295
0.040
Why?
Phylogeny
1
2022
229
0.040
Why?
Syndecan-1
1
2021
73
0.040
Why?
RANK Ligand
1
2022
187
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
90
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Clone Cells
1
2021
76
0.040
Why?
Chromatin
1
2021
141
0.040
Why?
Pyrimidines
1
2022
198
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
232
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
63
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
225
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Cell Line, Tumor
1
2023
1418
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Genetic Variation
1
2020
224
0.040
Why?
Health Status Disparities
1
2022
216
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
174
0.040
Why?
Multivariate Analysis
1
2021
600
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
Why?
Syndrome
1
2019
247
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
424
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.030
Why?
Oncogene Proteins, Fusion
1
2018
60
0.030
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.030
Why?
Protein-Tyrosine Kinases
1
2018
87
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
Retinoblastoma Protein
1
2017
19
0.030
Why?
STAT3 Transcription Factor
1
2017
86
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Fibroblast Growth Factors
1
2017
49
0.030
Why?
Bone and Bones
1
2021
492
0.030
Why?
Glomerular Filtration Rate
1
2017
127
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
Why?
Amino Acid Sequence
1
2018
566
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
Sequence Analysis, DNA
1
2017
219
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
NF-kappa B
1
2018
329
0.030
Why?
DNA Methylation
1
2020
583
0.030
Why?
Glycolysis
1
2016
72
0.030
Why?
Staphylococcal Infections
1
2019
272
0.030
Why?
Models, Genetic
1
2016
173
0.030
Why?
Genomic Instability
1
2016
89
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
96
0.030
Why?
Logistic Models
1
2018
925
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
149
0.030
Why?
Melphalan
1
2016
178
0.030
Why?
Heart
1
2017
360
0.030
Why?
Kidney Diseases
1
2017
229
0.030
Why?
Algorithms
1
2018
663
0.030
Why?
Echocardiography
1
2017
415
0.030
Why?
Time Factors
1
2021
2970
0.030
Why?
Thalidomide
1
2016
377
0.030
Why?
Disease Management
1
2015
185
0.030
Why?
Myocardium
1
2017
477
0.030
Why?
Longitudinal Studies
1
2016
742
0.030
Why?
Risk Assessment
1
2018
1339
0.030
Why?
Dose-Response Relationship, Drug
1
2016
1368
0.020
Why?
Ifosfamide
1
2011
9
0.020
Why?
Dacarbazine
1
2011
11
0.020
Why?
Tomography, X-Ray Computed
1
2017
1148
0.020
Why?
Carboplatin
1
2011
56
0.020
Why?
Etoposide
1
2011
71
0.020
Why?
United States
1
2022
5168
0.020
Why?
Fatal Outcome
1
2011
192
0.020
Why?
Treatment Failure
1
2011
122
0.020
Why?
Drug Administration Schedule
1
2011
374
0.020
Why?
Magnetic Resonance Imaging
1
2017
1518
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description